Pressure Ulcers Stage III Clinical Trial
Official title:
A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
The primary objective of these case series is to evaluate the safety and tolerability of the KLOX BioPhotonic System as adjunctive therapy to Standard Of Care (SOC) in patients with stage II or III pressure ulcers.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04311229 -
Effectiveness of Negative-Pressure Wound Therapy
|
N/A | |
| Recruiting |
NCT05894291 -
Comparaison of Two Prone Position Techniques on Occurence of Pressure Sores in ICU
|
N/A | |
| Not yet recruiting |
NCT05649332 -
Study to Evaluate the Performance and Safety of the Medical Device Argogen
|
N/A | |
| Completed |
NCT05130814 -
EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
|
N/A | |
| Recruiting |
NCT03038490 -
The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers
|
N/A | |
| Recruiting |
NCT05496296 -
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
|
N/A | |
| Completed |
NCT03283787 -
Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries
|
N/A |